Seeking Alpha

Matrixx Initiatives Inc. (MTXX)

()

News & PR
Market Currents

Buzz
Twitter: MTXX

Business Intelligence
Transcripts
Events
Key Developments

Instablog posts on MTXX

Are Your Healthcare Stocks Now on the Reshuffled NASDAQ Biotechnology Index? by M. E. Garza
Biotech investors should take note that some of their favorite stocks may soon be listed as part of a recognized index for the first time. On Friday, the NASDAQ OMX Group, Inc. announced their semi-annual re-ranking of the NASDAQ Biotechnology Index (Nasdaq:NBI), which will become effective with... More »
November 15, 2009 • SPPI, PARD, CSKI
Zinc in Denture Cremes; Another P&G Product Tainted... Zicam, Patches and FDA [GSK,PG,MTXX] by Onpointadvisor
Lawyers filed suit against Poligrip (Glaxo, GSK) and Fixodent (P&G, PG) denture adhesives alleging that zinc salts in their formulae caused serious neurological deficits. The logic has merit and may affect other OTC products and how they are regulated by FDA...Read more at: ... More »
September 26, 2009 • GSK, PG, MTXX
Looking For Out-of-Favor Stocks by Davy Bui
One of the perks of being a certified Seeking Alpha contributor is access to various research tools like Zacks.com. Zacks is an investment research service primarily oriented toward momentum and growth investing so their recommended stocks tend to be closer to 52-week highs than to the lows.... More »
September 9, 2009 • ARKR, ARLP, ATI
Four Small-Cap Biotechs: FDA Favors Two, Denies Two by Small Cap Network
MELA, AMAG, ANDS, MTXX In Own BattlesSo many small-cap biotech companies struggling to get their first products to market are turned away by the almighty Food and Drug Administration (FDA). It reminds me of the all-knowing Wizard of Oz as he listened intently to what people were asking for or... More »
July 8, 2009 • AMAG, MELA, ANDS
Matrixx Initiatives - A critical test of crisis management in a litigious society with a newly zealous FDA by Mark Mansfield
We have seen a decimation in the shares of Matrixx Intiatives as a result of the FDA’s June 16th warning letter indicating anosmia experienced in a group of several hundred Zicam nasal product users. Initially Matrixx went into defensive mode, but has since “voluntarily”... More »
July 5, 2009 • MTXX
Looking For Solid, Growing Companies In A Recession by Davy Bui
In dedication to my recent posts on value investing vs. trading strategies, I decided to focus this week's screen to the market's favorite word: growth. Specifically, the criteria used was positive revenue growth for the next fiscal year. Of course, this does not translate to earnings growth but... More »
June 29, 2009 • AAON, ACN, ARO
The "Obama Flu" and the Zicam Hysteria of 2009 [MTXX] by Onpointadvisor
"Who is John Galt?" - Ayn Rand, Atlas Shrugged, 1957 The emergence of a new strain of influenza A/H1N1 virus this year created pandemic hysteria diverting attention away from more recent and sexier flu strains like H5N1 taking us back to the day when virulent strains termed Asian... More »
June 25, 2009 • MTXX
FDA Calendar Updates: BDSI is Worth the Wait, Zicam Warning by Mike Havrilla
Below is a summary of updates to the BioMedReports.com FDA Calendar, which includes a database of over 200 entries. The calendar was originally created by Mike Havrilla to track companies with pending new drug, biological agent, or medical device new product decisions at the FDA. With the launch... More »
June 16, 2009 • BDSI, MTXX, ARYX

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Matrixx Initiatives Inc. (MTXX)

Instablog posts on MTXX

Are Your Healthcare Stocks Now on the Reshuffled NASDAQ Biotechnology Index? by M. E. Garza

Zinc in Denture Cremes; Another P&G Product Tainted... Zicam, Patches and FDA [GSK,PG,MTXX] by Onpointadvisor

Looking For Out-of-Favor Stocks by Davy Bui

Four Small-Cap Biotechs: FDA Favors Two, Denies Two by Small Cap Network

Matrixx Initiatives - A critical test of crisis management in a litigious society with a newly zealous FDA by Mark Mansfield

Looking For Solid, Growing Companies In A Recession by Davy Bui

The "Obama Flu" and the Zicam Hysteria of 2009 [MTXX] by Onpointadvisor

FDA Calendar Updates: BDSI is Worth the Wait, Zicam Warning by Mike Havrilla

The Seeking Alpha 100

Fastest Climbers

Top Commenters

Top Instabloggers

Top StockTalkers